Determination of plasma flunarizine hydrochloride dispersible tablets by HPLC

Zhen-sheng LIU,Yan ZHAO,Mei-xing YAN,An-jin CHEN,Shao-hua WANG

DOI: https://doi.org/10.3321/j.issn:1003-3734.2005.08.032

2005-01-01

Abstract:Objective:To determine the plasma concentration and pharmacokinetic parameters of flunarizine hydrochloride dispersible tablets by HPLC. Methods:10 healthy volunteers were administered with a single dose of flunarizine hydrochloride dispersible tablets (20 mg). Plasma concentrations of flunarizine hydrochloride were measured by HPLC. The HPLC conditions were as follows: Diamod TM C_ 18 column (150 mm× 4.6 mm,5 μm), an eluant consisted of 0.01 mol·L -1 ammonium dihydrogen phosphate buffer-methanol (35∶65, pH=3.5 adjusted with phosphoric acid) with a flow rate of 1.0 mL·min -1 , and fluorescence detection at Ex=254 nm and Em=308 nm. Propyl p-hydroxy benzoate was used as an internal standard.Results:The linear plot of concentration versus of peak area of internal standard was found in the range of 1.5～100 ng·mL -1 ( r =0.999 8 ). The mean recovery rate of three batches of plasma sample concentrations was within 99.10%～101.88% with within-day and among-day RSD of 1.99%～4.44%. The pharmacokinetic parameters after administration of flunarizine hydrochloride dispersible tablets (20mg) were shown as AUC_ 0- t (424.27±74.01) ng·h·mL -1 ; C _ max (67.02±14.89) ng·mL -1 ; T _ max (2.90±0.42)h, and t _ 1/2 K e (9.73±3.15)h. Conclusion:The methodology to determine plasma concentration and pharmacokinetic profiles of flunarizine hydrochloride dispersible tablets by HPLC were achieved.